Transthyretin Mediated Amyloidosis (ATTR) Completed Phase 1 Trials for Vutrisiran (DB16699)

Also known as: Transthyretin-Mediated Amyloidosis / Transthyretin-mediated Amyloidosis (ATTR Amyloidosis) / Amyloidogenic Transthyretin (ATTR) Amyloidosis / Transthyretin (TTR)-Mediated Amyloidosis / Amyloidosis in Transthyretin (TTR) / Amyloid Transthyretin (ATTR) Amyloidosis / ATTR Amyloidosis

IndicationStatusPhase
DBCOND0047425 (Transthyretin Mediated Amyloidosis (ATTR))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02797847A Safety and Tolerability Study of an Investigational Drug, ALN-TTRSC02, in Healthy SubjectsTreatment